215 related articles for article (PubMed ID: 23920106)
1. Catalog of mRNA expression patterns for DNA methylating and demethylating genes in developing mouse lower urinary tract.
Keil KP; Altmann HM; Mehta V; Abler LL; Elton EA; Vezina CM
Gene Expr Patterns; 2013 Dec; 13(8):413-24. PubMed ID: 23920106
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor DNA methylation regulates the timing and androgen sensitivity of mouse prostate ductal development.
Keil KP; Abler LL; Laporta J; Altmann HM; Yang B; Jarrard DF; Hernandez LL; Vezina CM
Dev Biol; 2014 Dec; 396(2):237-45. PubMed ID: 25446526
[TBL] [Abstract][Full Text] [Related]
3. Wnt inhibitory factor 1 (Wif1) is regulated by androgens and enhances androgen-dependent prostate development.
Keil KP; Mehta V; Branam AM; Abler LL; Buresh-Stiemke RA; Joshi PS; Schmitz CT; Marker PC; Vezina CM
Endocrinology; 2012 Dec; 153(12):6091-103. PubMed ID: 23087175
[TBL] [Abstract][Full Text] [Related]
4. Visualization and quantification of mouse prostate development by in situ hybridization.
Keil KP; Mehta V; Abler LL; Joshi PS; Schmitz CT; Vezina CM
Differentiation; 2012 Oct; 84(3):232-9. PubMed ID: 22898663
[TBL] [Abstract][Full Text] [Related]
5. A high throughput in situ hybridization method to characterize mRNA expression patterns in the fetal mouse lower urogenital tract.
Abler LL; Mehta V; Keil KP; Joshi PS; Flucus CL; Hardin HA; Schmitz CT; Vezina CM
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21876526
[TBL] [Abstract][Full Text] [Related]
6. Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.
Fukuhara S; Chang I; Mitsui Y; Chiyomaru T; Yamamura S; Majid S; Saini S; Deng G; Gill A; Wong DK; Shiina H; Nonomura N; Lau YF; Dahiya R; Tanaka Y
Oncotarget; 2015 Jun; 6(18):16341-51. PubMed ID: 26036629
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation of E-cadherin is a priming mechanism for prostate development.
Keil KP; Abler LL; Mehta V; Altmann HM; Laporta J; Plisch EH; Suresh M; Hernandez LL; Vezina CM
Dev Biol; 2014 Mar; 387(2):142-53. PubMed ID: 24503032
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptors in urogenital sinus mesenchyme mediate the inhibition of prostatic epithelial bud formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Ko K; Moore RW; Peterson RE
Toxicol Appl Pharmacol; 2004 Apr; 196(1):149-55. PubMed ID: 15050416
[TBL] [Abstract][Full Text] [Related]
9. Dioxin causes ventral prostate agenesis by disrupting dorsoventral patterning in developing mouse prostate.
Vezina CM; Allgeier SH; Moore RW; Lin TM; Bemis JC; Hardin HA; Gasiewicz TA; Peterson RE
Toxicol Sci; 2008 Dec; 106(2):488-96. PubMed ID: 18779384
[TBL] [Abstract][Full Text] [Related]
10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits fibroblast growth factor 10-induced prostatic bud formation in mouse urogenital sinus.
Vezina CM; Hardin HA; Moore RW; Allgeier SH; Peterson RE
Toxicol Sci; 2010 Jan; 113(1):198-206. PubMed ID: 19805408
[TBL] [Abstract][Full Text] [Related]
11. Influence of oxidized purine processing on strand directionality of mismatch repair.
Repmann S; Olivera-Harris M; Jiricny J
J Biol Chem; 2015 Apr; 290(16):9986-99. PubMed ID: 25694431
[TBL] [Abstract][Full Text] [Related]
12. Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.
Duan Z; Zou JX; Yang P; Wang Y; Borowsky AD; Gao AC; Chen HW
Prostate; 2013 Apr; 73(5):455-66. PubMed ID: 23038103
[TBL] [Abstract][Full Text] [Related]
13. Ornithine Decarboxylase Activity Is Required for Prostatic Budding in the Developing Mouse Prostate.
Gamat M; Malinowski RL; Parkhurst LJ; Steinke LM; Marker PC
PLoS One; 2015; 10(10):e0139522. PubMed ID: 26426536
[TBL] [Abstract][Full Text] [Related]
14. Evidence that inhibited prostatic epithelial bud formation in 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed C57BL/6J fetal mice is not due to interruption of androgen signaling in the urogenital sinus.
Ko K; Theobald HM; Moore RW; Peterson RE
Toxicol Sci; 2004 Jun; 79(2):360-9. PubMed ID: 15056816
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
[TBL] [Abstract][Full Text] [Related]
16. Effects of TCDD on Ah receptor, ARNT, EGF, and TGF-alpha expression in embryonic mouse urinary tract.
Bryant PL; Clark GC; Probst MR; Abbott BD
Teratology; 1997 May; 55(5):326-37. PubMed ID: 9261927
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer.
Truninger K; Menigatti M; Luz J; Russell A; Haider R; Gebbers JO; Bannwart F; Yurtsever H; Neuweiler J; Riehle HM; Cattaruzza MS; Heinimann K; Schär P; Jiricny J; Marra G
Gastroenterology; 2005 May; 128(5):1160-71. PubMed ID: 15887099
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor signaling through MEK-ERK is required for prostate bud induction.
Kuslak SL; Marker PC
Differentiation; 2007 Sep; 75(7):638-51. PubMed ID: 17309601
[TBL] [Abstract][Full Text] [Related]
19. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
20. Effect of carcinogenic acrolein on DNA repair and mutagenic susceptibility.
Wang HT; Hu Y; Tong D; Huang J; Gu L; Wu XR; Chung FL; Li GM; Tang MS
J Biol Chem; 2012 Apr; 287(15):12379-86. PubMed ID: 22275365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
